Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results

BACKGROUND: To evaluate the efficacy of first-line bevacizumab-based chemotherapy for untreated metastatic colorectal cancer (mCRC) based on age. METHODS: Eligibility criteria focused on M1 disease without prior palliative chemotherapy. Choice of chemotherapy regimen was at the physician’s discretio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofheinz, Ralf, Petersen, Volker, Kindler, Manfred, Schulze, Mathias, Seraphin, Joerg, Hoeffkes, Heinz-Gert, Valdix, Anette-R, Schroeder, Jan, Herrenberger, Julia, Stein, Alexander, Hinke, Axel, Arnold, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198800/
https://www.ncbi.nlm.nih.gov/pubmed/25311943
http://dx.doi.org/10.1186/1471-2407-14-761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198800/
https://www.ncbi.nlm.nih.gov/pubmed/25311943
http://dx.doi.org/10.1186/1471-2407-14-761

Ejemplares similares